Case studies
Learn how BostonGene has already strengthened performance at every phase of drug development.
Prioritize indications and subtypes based on molecular signals
AI and digital twins predict therapy response and unlock high-value indications
Learn more
Stratify patients and optimize trials with AI-driven classifiers
AI classifier enables leaner trials with precise patient targeting
Learn more
Identify BTK-inh responder cohort to support label expansion
AI reveals responder cohorts to accelerate label expansion opportunities
Learn more
